bupropion has been researched along with Diabetes Mellitus in 8 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Naltrexone/bupropion is an investigational combination for weight loss and maintenance in patients who are obese or have a BMI ≥ 27 kg/m(2) with comorbid diabetes, hypertension or hyperlipidemia." | 8.87 | Naltrexone/bupropion: an investigational combination for weight loss and maintenance. ( Gwinn, KM; Hurren, KM; Makowski, CT, 2011) |
| "Naltrexone/bupropion is an investigational combination for weight loss and maintenance in patients who are obese or have a BMI ≥ 27 kg/m(2) with comorbid diabetes, hypertension or hyperlipidemia." | 4.87 | Naltrexone/bupropion: an investigational combination for weight loss and maintenance. ( Gwinn, KM; Hurren, KM; Makowski, CT, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brath, H | 2 |
| Kaser, S | 2 |
| Tatschl, C | 2 |
| Fischer-See, S | 1 |
| Fasching, P | 2 |
| Majd, H | 1 |
| Amin, S | 1 |
| Ghazizadeh, Z | 1 |
| Cesiulis, A | 1 |
| Arroyo, E | 1 |
| Lankford, K | 1 |
| Majd, A | 1 |
| Farahvashi, S | 1 |
| Chemel, AK | 1 |
| Okoye, M | 1 |
| Scantlen, MD | 1 |
| Tchieu, J | 1 |
| Calder, EL | 1 |
| Le Rouzic, V | 1 |
| Shibata, B | 1 |
| Arab, A | 1 |
| Goodarzi, H | 1 |
| Pasternak, G | 1 |
| Kocsis, JD | 1 |
| Chen, S | 1 |
| Studer, L | 1 |
| Fattahi, F | 1 |
| Fujioka, K | 1 |
| McGinty, EE | 1 |
| Baller, J | 1 |
| Azrin, ST | 1 |
| Juliano-Bult, D | 1 |
| Daumit, GL | 1 |
| Silva, AP | 1 |
| Scholz, J | 1 |
| Abe, TO | 1 |
| Pinheiro, GG | 1 |
| Gaya, PV | 1 |
| Pereira, AC | 1 |
| Santos, PC | 1 |
| Roopan, S | 1 |
| Larsen, ER | 1 |
| Makowski, CT | 1 |
| Gwinn, KM | 1 |
| Hurren, KM | 1 |
5 reviews available for bupropion and Diabetes Mellitus
| Article | Year |
|---|---|
[Smoking, alcohol and diabetes (Update 2019)].
Topics: Alcohol Drinking; Benzazepines; Bupropion; Diabetes Mellitus; Humans; Nicotine; Practice Guidelines | 2019 |
Current and emerging medications for overweight or obesity in people with comorbidities.
Topics: Anti-Obesity Agents; Bupropion; Cinnamates; Comorbidity; Cyclohexanes; Diabetes Mellitus; Dyslipidem | 2015 |
Interventions to Address Medical Conditions and Health-Risk Behaviors Among Persons With Serious Mental Illness: A Comprehensive Review.
Topics: Behavior Therapy; Bipolar Disorder; Bupropion; Cardiovascular Diseases; Diabetes Mellitus; Dopamine | 2016 |
Use of antidepressants in patients with depression and comorbid diabetes mellitus: a systematic review.
Topics: Acetamides; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepres | 2017 |
Naltrexone/bupropion: an investigational combination for weight loss and maintenance.
Topics: Anti-Obesity Agents; Bupropion; Diabetes Mellitus; Drug Therapy, Combination; Glycated Hemoglobin; H | 2011 |
3 other studies available for bupropion and Diabetes Mellitus
| Article | Year |
|---|---|
[Smoking, heated tobacco products, alcohol and diabetes mellitus (update 2023)].
Topics: Benzazepines; Bupropion; Diabetes Mellitus; Electronic Nicotine Delivery Systems; Ethanol; Humans; N | 2023 |
Deriving Schwann cells from hPSCs enables disease modeling and drug discovery for diabetic peripheral neuropathy.
Topics: Animals; Bupropion; Diabetes Mellitus; Diabetic Neuropathies; Drug Discovery; Humans; Mice; Retrospe | 2023 |
Influence of smoking cessation drugs on blood pressure and heart rate in patients with cardiovascular disease or high risk score: real life setting.
Topics: Adult; Aged; Blood Pressure; Brazil; Bupropion; Cardiovascular Diseases; Comorbidity; Coronary Arter | 2016 |